Antonio Maurizi

2.0k total citations · 2 hit papers
39 papers, 1.6k citations indexed

About

Antonio Maurizi is a scholar working on Molecular Biology, Oncology and Rheumatology. According to data from OpenAlex, Antonio Maurizi has authored 39 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 16 papers in Oncology and 7 papers in Rheumatology. Recurrent topics in Antonio Maurizi's work include Bone Metabolism and Diseases (18 papers), Bone health and treatments (11 papers) and Biomarkers in Disease Mechanisms (5 papers). Antonio Maurizi is often cited by papers focused on Bone Metabolism and Diseases (18 papers), Bone health and treatments (11 papers) and Biomarkers in Disease Mechanisms (5 papers). Antonio Maurizi collaborates with scholars based in Italy, United States and Austria. Antonio Maurizi's co-authors include Nadia Rucci, Anna Teti, Alfredo Cappariello, Jeffrey E. Pessin, Haihong Zong, Vimal Veeriah, Takashi Iezaki, Eiichi Hinoi, Daisuke Kajimura and Gérard Karsenty and has published in prestigious journals such as Nature, Cell and Journal of Biological Chemistry.

In The Last Decade

Antonio Maurizi

36 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Glucose Uptake and Runx2 Synergize to Orchestrate Osteoblast Differentiation and Bone Formation

2015 363 citations Jianwen Wei, Munevver Parla Makinistoglu et al. Cell profile →
MC4R-dependent suppression of appetite by bone-derived lipocalin 2

2017 325 citations Antonio Maurizi, Haihong Zong et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Antonio Maurizi Italy	16	949	434	292	229	206	39	1.6k
Anyonya R. Guntur United States	22	953 1.0×	239 0.6×	293 1.0×	221 1.0×	342 1.7×	36	1.6k
Kenichi Nagano United States	23	812 0.9×	295 0.7×	201 0.7×	185 0.8×	232 1.1×	48	1.4k
Yuiko Sato Japan	23	649 0.7×	364 0.8×	172 0.6×	321 1.4×	177 0.9×	59	1.4k
Chun Guo China	26	974 1.0×	347 0.8×	203 0.7×	167 0.7×	207 1.0×	56	1.8k
Angela Oranger Italy	23	738 0.8×	444 1.0×	118 0.4×	184 0.8×	368 1.8×	52	1.6k
Arancha R. Gortázar Spain	20	1.0k 1.1×	535 1.2×	108 0.4×	383 1.7×	224 1.1×	39	1.7k
Srividhya Iyer United States	16	1.0k 1.1×	316 0.7×	221 0.8×	286 1.2×	284 1.4×	22	1.5k
Jonathan H. Gooi Australia	20	1.3k 1.4×	693 1.6×	134 0.5×	437 1.9×	202 1.0×	37	2.1k
Emma Persson Sweden	21	748 0.8×	481 1.1×	222 0.8×	126 0.6×	116 0.6×	39	1.5k
Ingrid Stockmans Belgium	19	1.3k 1.3×	353 0.8×	392 1.3×	276 1.2×	234 1.1×	32	2.6k

Countries citing papers authored by Antonio Maurizi

Since Specialization

Citations

This map shows the geographic impact of Antonio Maurizi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Maurizi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Maurizi more than expected).

Fields of papers citing papers by Antonio Maurizi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Maurizi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Maurizi. The network helps show where Antonio Maurizi may publish in the future.

Co-authorship network of co-authors of Antonio Maurizi

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Maurizi. A scholar is included among the top collaborators of Antonio Maurizi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Maurizi. Antonio Maurizi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Alam, Imranul, Ashkan Dehsorkhi, Paulina Rachwalska, et al.. (2024). Effect of Allele-Specific Clcn7G213R siRNA Delivered Via a Novel Nanocarrier on Bone Phenotypes in ADO2 Mice on 129S Background. Calcified Tissue International. 115(1). 85–96. 1 indexed citations

Ponzetti, Marco, Patrick Lau, Petra Frings‐Meuthen, et al.. (2024). Pre-proenkephalin 1 is Downregulated Under Unloading and is Involved in Osteoblast Biology. Calcified Tissue International. 114(5). 524–534. 1 indexed citations

Maurizi, Antonio, Ahmed El‐Gazzar, Maria Luisa Brandi, et al.. (2023). High bone mass disorders: New insights from connecting the clinic and the bench. Yearbook of pediatric endocrinology. 2 indexed citations

Maurizi, Antonio, Anna Teti, Paulina Rachwalska, et al.. (2023). Novel hybrid silicon-lipid nanoparticles deliver a siRNA to cure autosomal dominant osteopetrosis in mice. Implications for gene therapy in humans. Molecular Therapy — Nucleic Acids. 33. 925–937. 9 indexed citations

Ponzetti, Marco, et al.. (2022). Lipocalin 2 Influences Bone and Muscle Phenotype in the MDX Mouse Model of Duchenne Muscular Dystrophy. International Journal of Molecular Sciences. 23(2). 958–958. 17 indexed citations

Maurizi, Antonio. (2022). Experimental therapies for osteopetrosis. Bone. 165. 116567–116567. 4 indexed citations

Maurizi, Antonio, Marco Ponzetti, Kaare M. Gautvik, et al.. (2021). Lipocalin 2 serum levels correlate with age and bone turnover biomarkers in healthy subjects but not in postmenopausal osteoporotic women. Bone Reports. 14. 101059–101059. 14 indexed citations

Paganini, Chiara, Luca Monti, Antonio Maurizi, et al.. (2021). Improvement of the skeletal phenotype in a mouse model of diastrophic dysplasia after postnatal treatment with N-acetylcysteine. Biochemical Pharmacology. 185. 114452–114452. 13 indexed citations

Bergen, Dylan J. M., Antonio Maurizi, Melissa M. Formosa, et al.. (2020). High Bone Mass Disorders: New Insights From Connecting the Clinic and the Bench. Journal of Bone and Mineral Research. 38(2). 229–247. 6 indexed citations

10.

Maurizi, Antonio, Mattia Capulli, Shireen R. Lamandé, et al.. (2019). Extra-skeletal manifestations in mice affected by Clcn7-dependent autosomal dominant osteopetrosis type 2 clinical and therapeutic implications. Bone Research. 7(1). 17–17. 12 indexed citations

11.

Capulli, Mattia, Marco Ponzetti, Antonio Maurizi, et al.. (2018). A Complex Role for Lipocalin 2 in Bone Metabolism: Global Ablation in Mice Induces Osteopenia Caused by an Altered Energy Metabolism. Journal of Bone and Mineral Research. 33(6). 1141–1153. 46 indexed citations

12.

Cappariello, Alfredo, et al.. (2017). Osteoblast-Derived Extracellular Vesicles Are Biological Tools for the Delivery of Active Molecules to Bone. Journal of Bone and Mineral Research. 33(3). 517–533. 108 indexed citations

13.

Maurizi, Antonio, et al.. (2016). Storage disease and neurological phenotype in autosomal dominant osteopetrosis type 2 (ADO2). A preclinical study. Bone Abstracts. 1 indexed citations

14.

Thaler, Roman, Antonio Maurizi, Paul Roschger, et al.. (2016). Anabolic and Antiresorptive Modulation of Bone Homeostasis by the Epigenetic Modulator Sulforaphane, a Naturally Occurring Isothiocyanate. Journal of Biological Chemistry. 291(13). 6754–6771. 59 indexed citations

15.

Wei, Jianwen, Munevver Parla Makinistoglu, Antonio Maurizi, et al.. (2015). Glucose Uptake and Runx2 Synergize to Orchestrate Osteoblast Differentiation and Bone Formation. Cell. 161(7). 1576–1591. 363 indexed citations breakdown →

16.

Cappariello, Alfredo, Riccardo Paone, Antonio Maurizi, et al.. (2015). Biotechnological approach for systemic delivery of membrane Receptor Activator of NF-κB Ligand (RANKL) active domain into the circulation. Biomaterials. 46. 58–69. 22 indexed citations

17.

Capulli, Mattia, Antonio Maurizi, Luca Ventura, Nadia Rucci, & Anna Teti. (2015). Small interfering RNAs as an innovative therapeutic approach for the autosomal dominant osteopetrosis type 2 (ADO2). Bone Abstracts. 1 indexed citations

18.

Capulli, Mattia, Antonio Maurizi, Luca Ventura, Nadia Rucci, & Anna Teti. (2015). Effective Small Interfering RNA Therapy to Treat CLCN7-dependent Autosomal Dominant Osteopetrosis Type 2. Molecular Therapy — Nucleic Acids. 4. e248–e248. 21 indexed citations

19.

Cappariello, Alfredo, Antonio Maurizi, Vimal Veeriah, & Anna Teti. (2014). The Great Beauty of the osteoclast. Archives of Biochemistry and Biophysics. 558. 70–78. 164 indexed citations

20.

Alam, Imranul, Amie K. Gray, Shoji Ichikawa, et al.. (2013). Generation of the first autosomal dominant osteopetrosis type II (ADO2) disease models. Bone. 59. 66–75. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact